ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)

Market Cap	3.18B
Revenue (ttm)	536.35M
Net Income (ttm)	80.67M
Shares Out	112.42M
EPS (ttm)	0.71
PE Ratio	40.09
Forward PE	20.66
Dividend	0.20 (0.71%)
Ex-Dividend Date	Jun 14, 2024

Volume	6,095,734
Average Volume	9,545,125
Open	29.85
Previous Close	28.30
Day's Range	28.33 - 30.13
52-Week Range	19.40 - 36.98
Beta	0.69
RSI	58.84
Earnings Date	Apr 25, 2025

About ChengDu ShengNuo Biotec

ChengDu ShengNuo Biotec Co.,Ltd. engages in the research and development, production, sale, and export of peptide drugs. The company produces polypeptide APIs, tablets of solid preparation, bottles of freeze-dried powder injections, small-volume injections, pre-filled injections, and card type injections. ChengDu ShengNuo Biotec Co.,Ltd. was founded in 2001 and is based in Chengdu, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 1,128
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688117

Financial Performance

In 2024, ChengDu ShengNuo Biotec's revenue was 456.07 million, an increase of 4.84% compared to the previous year's 435.02 million. Earnings were 50.02 million, a decrease of -28.88%.